A detailed history of 2 Xideas Ag transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, 2 Xideas Ag holds 95,569 shares of LNTH stock, worth $7.28 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
95,569
Previous 176,720 45.92%
Holding current value
$7.28 Million
Previous $14.2 Million 26.08%
% of portfolio
1.54%
Previous 1.88%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$77.7 - $123.62 $6.31 Million - $10 Million
-81,151 Reduced 45.92%
95,569 $10.5 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $337,501 - $476,125
5,733 Added 3.35%
176,720 $14.2 Million
Q1 2024

May 16, 2024

BUY
$51.07 - $68.26 $8.37 Million - $11.2 Million
163,907 Added 2315.07%
170,987 $10.6 Million
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $361,575 - $483,280
7,080 New
7,080 $440,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.24B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track 2 Xideas Ag Portfolio

Follow 2 Xideas Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

News

Stay updated on 2 Xideas Ag with notifications on news.